乌鸦传媒

ARTESiA trial analysis suggests a key threshold for CHA2DS2-VASc score

Trial suggests a possible disease modifying benefit

Modular leadless system could expand S-ICD use by offering painless anti-tachycardia pacing

Randomized trial fails to show benefit except in one group

Next-gen Medtronic ICD lead wire meets pivotal trial safety and efficacy endpoints

Randomized trial proves advantage of tailored targets

Study reassures, but long dwell times are largely yet to come

U.S. guidelines finally address LBB pacing, His bundle pacing

Anti-tachycardia pacing prevented shocks in about half of cases

Non-invasive vagus nerve stimulator shows promise in proof-of-concept trial

High-risk patients do not get benefits from devices, observational study finds

Compared with biventricular pacing, increase in LVEF was found to be significant

"Any strategy to reduce infection rates in these patients is important," expert says

Device provided atrial pacing, reliable atrioventricular synchrony for 3 months post-implantation